Economy of New York City

Epizyme Announces Date of Second Quarter 2021 Financial Results

Retrieved on: 
Tuesday, August 3, 2021
Biotechnology, Pharmaceutical, Health, Oncology, Life sciences, Biotechnology, Articles, Economy of New York City, NASDAQ, Biopharmaceutical

Epizyme , (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that management will host a conference call to discuss its second quarter 2021 financial results and provide a business update on Monday, August 9, 2021 at 8:30 a.m.

Key Points: 
  • Epizyme , (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that management will host a conference call to discuss its second quarter 2021 financial results and provide a business update on Monday, August 9, 2021 at 8:30 a.m.
  • To participate in the conference call, please dial (877) 844-6886 (domestic) or (970) 315-0315 (international) and refer to conference ID 3658407.
  • By focusing on the genetic drivers of disease, Epizyme seeks to match medicines with the patients who need them.
  • TAZVERIK is a registered trademark of Epizyme, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210803006035/en/

MSCI Launches Private Offering of $700 Million Senior Unsecured Notes Due 2033; To Redeem 5.375% Notes Due 2027

Retrieved on: 
Tuesday, August 3, 2021
Finance, Data management, Professional services, Other Technology, Technology, Exchange-traded funds, MSCI, Morgan Stanley, Financial markets, Finance, Economy of New York City

If the offering is successfully placed, MSCI intends to use the net proceeds from the offering to redeem all $500.0 million aggregate principal amount of its 5.375% senior unsecured notes due 2027 (the 2027 Notes), as well as for general corporate purposes (including, without limitation, potential purchases of MSCIs common stock, investments and acquisitions) and to pay related redemption costs.

Key Points: 
  • If the offering is successfully placed, MSCI intends to use the net proceeds from the offering to redeem all $500.0 million aggregate principal amount of its 5.375% senior unsecured notes due 2027 (the 2027 Notes), as well as for general corporate purposes (including, without limitation, potential purchases of MSCIs common stock, investments and acquisitions) and to pay related redemption costs.
  • This press release does not constitute a notice of redemption with respect to the 2027 Notes.
  • MSCI is a leading provider of critical decision support tools and services for the global investment community.
  • This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Seres Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates

Retrieved on: 
Tuesday, August 3, 2021
Research, FDA, Clinical trials, Stem cells, Biotechnology, Health, Pharmaceutical, Other Science, Science, Economy of New York City, NASDAQ, Chief financial officer, Business, Finance, Economy

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome company developing a novel class of multifunctional bacterial therapeutics designed to functionally interact with host cells and tissues to treat disease, today reported second quarter 2021 financial results and provided business updates.

Key Points: 
  • Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome company developing a novel class of multifunctional bacterial therapeutics designed to functionally interact with host cells and tissues to treat disease, today reported second quarter 2021 financial results and provided business updates.
  • Appointment of Chief Financial Officer and Head of Business Development: In May, Seres announced that David Arkowitz was appointed as Executive Vice President, Chief Financial Officer (CFO) and Head of Business Development.
  • Research and development expenses for the second quarter of 2021 were $36.0 million, compared with $20.1 million for the same period in 2020.
  • General and administrative expenses for the second quarter of 2021 were $17.5 million, compared with $6.5 million for the same period in 2020.

Adtalem Global Education Announces Fourth-Quarter and Full-Year Fiscal 2021 Conference Call

Retrieved on: 
Tuesday, August 3, 2021
University, Education, Adtalem Global Education, Downers Grove, Illinois, Conference call, Wardell, New York Stock Exchange, Companies, Service companies, Economy of New York City

Adtalem Global Education (NYSE: ATGE), a leading workforce solutions provider, announced today it will hold a conference call to discuss its fiscal 2021 fourth quarter and full year results on Thursday, Aug. 19, 2021, at 4 p.m. CT (5 p.m.

Key Points: 
  • Adtalem Global Education (NYSE: ATGE), a leading workforce solutions provider, announced today it will hold a conference call to discuss its fiscal 2021 fourth quarter and full year results on Thursday, Aug. 19, 2021, at 4 p.m. CT (5 p.m.
  • The conference call will be led by Lisa Wardell, chairman and chief executive officer, and Bob Phelan, interim chief financial officer.
  • For those participating by telephone, dial 877-407-6184 (United States) or +1 201-389-0877 (outside the United States) and request the Adtalem Call or use conference ID: 13721922.
  • The purpose of Adtalem Global Education is to empower students and members to achieve their goals, find success, and make inspiring contributions to our global community.

The Real Brokerage Inc. Announces Preferred Unit Exchange

Retrieved on: 
Tuesday, August 3, 2021
Economy of New York City, NASDAQ, Real estate agent, Marketing, Finance, Financial markets

NEW YORK and TORONTO, Aug. 3, 2021 /PRNewswire/ -- The Real Brokerage Inc. ("Real" or the "Company") (TSXV: REAX) (Nasdaq: REAX), a national, technology-powered real estate brokerage now operating in 31 states and the District of Columbia, announced today certain funds managed by Insight Venture Management LLC ("Insight Partners") have converted all of the issued and outstanding preferred units of Real PIPE, LLC ("Real PIPE" and the "Preferred Units") into an aggregate 17,286,848 common shares of Real ("Common Shares").

Key Points: 
  • NEW YORK and TORONTO, Aug. 3, 2021 /PRNewswire/ -- The Real Brokerage Inc. ("Real" or the "Company") (TSXV: REAX) (Nasdaq: REAX), a national, technology-powered real estate brokerage now operating in 31 states and the District of Columbia, announced today certain funds managed by Insight Venture Management LLC ("Insight Partners") have converted all of the issued and outstanding preferred units of Real PIPE, LLC ("Real PIPE" and the "Preferred Units") into an aggregate 17,286,848 common shares of Real ("Common Shares").
  • The issuance of Common Shares (the "Forced Exchange") follows Real's listing on The Nasdaq Capital Market (the "Nasdaq") on June 15, 2021.
  • In connection with the Nasdaq listing, Real delivered a "Forced Exchange Notice" to Insight Partners providing for the exchange of previously issued Preferred Units issued to Insight Partners pursuant to the terms of the Amended and Restated Limited Liability Company Agreement between Real, Real PIPE and Insight Partners dated December 2, 2020.
  • Real ( www.joinreal.com ) is a technology-powered real estate brokerage operating in 31 U.S. states and the District of Columbia.

Owl Rock Capital Corporation Announces Appointment of Jonathan Lamm as Chief Financial Officer

Retrieved on: 
Tuesday, August 3, 2021
Economy of New York City, Primary dealers, Subprime mortgage crisis, New York Stock Exchange, Finance, Ottawa Rape Crisis Centre, Lamm, Goldman Sachs, Banks

NEW YORK, Aug. 3, 2021 /PRNewswire/ -- Owl Rock Capital Corporation (NYSE: ORCC) ("ORCC") today announced that it has appointed Jonathan Lamm as its Chief Financial Officer and Chief Operating Officer, effective September 1, 2021.

Key Points: 
  • NEW YORK, Aug. 3, 2021 /PRNewswire/ -- Owl Rock Capital Corporation (NYSE: ORCC) ("ORCC") today announced that it has appointed Jonathan Lamm as its Chief Financial Officer and Chief Operating Officer, effective September 1, 2021.
  • From 2013 to 2021, Mr. Lamm served as Managing Director, Chief Operating Officer and Chief Financial Officer at GSAM Credit Alternatives.
  • From 2007 to 2013, Mr. Lamm served as Vice President, Chief Operating Officer and Chief Financial Officer at GSAM Credit Alternatives.
  • ORCC is externally managed by Owl Rock Capital Advisors LLC, an SEC-registered investment adviser that is an indirect subsidiary of Blue Owl Capital Inc. ("Blue Owl") (NYSE: OWL) and part of Owl Rock, a division of Blue Owl.

Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Tuesday, August 3, 2021
Medical specialties, Adjuvants, Health sciences, Health, Clinical trials, Economy of New York City, NASDAQ, Immunologic adjuvant, Vaccine

The stock options were granted on August 2, 2021 at an exercise price of $9.45 per share, which is equal to the closing price of Dynavax common stock on the date of grant.

Key Points: 
  • The stock options were granted on August 2, 2021 at an exercise price of $9.45 per share, which is equal to the closing price of Dynavax common stock on the date of grant.
  • The options were granted as a material inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4) and are subject to the terms and conditions of a stock option agreement covering the grant and Dynavax' 2021 Inducement Award Plan, which was adopted January 9, 2021 and provides for the granting of stock options to new employees.
  • Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines.
  • Dynavax is also advancing CpG 1018 adjuvant as a premier vaccine adjuvant through research collaborations and partnerships.

Macy's And Reading Is Fundamental Announce Charitable Round-up And Teacher Recognition To Support Children's Literacy This Back To School Season

Retrieved on: 
Tuesday, August 3, 2021
Midtown Manhattan, Economy of New York City, Macy's, Retailers, Retailing, Service companies, Midtown Manhattan, Economy of New York City, Macy's, Retailers, Retailing, Service companies

Additionally, Macy's will support RIF's newest reading initiative, Rally to Read 100, launching in September.

Key Points: 
  • Additionally, Macy's will support RIF's newest reading initiative, Rally to Read 100, launching in September.
  • Giving back is a core pillar of Macy's values and the longstanding partnership with RIF has resulted in a total contribution of more than $43 million toward children's literacy.
  • For more than 160 years, Macy's, the largest retail brand of Macy's, Inc., has served generations at every stage of their lives.
  • With fashion, value and celebration as our guide, Macy's makes life shine brighter for our customers, colleagues and communities.

Akerna to Announce Financial Results for the Second Quarter 2021 Ended June 30, 2021

Retrieved on: 
Tuesday, August 3, 2021
Business, Articles, Economy, Economy of New York City, NASDAQ, Enterprise resource planning

DENVER, Aug. 3, 2021 /PRNewswire/ -- Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry's first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), will report financial results for the second quarter ended June 30, 2021, on Monday, August 9, 2021.

Key Points: 
  • DENVER, Aug. 3, 2021 /PRNewswire/ --Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry's first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform), will report financial results for the second quarter ended June 30, 2021, on Monday, August 9, 2021.
  • Akerna will host a conference call at 8:30 a.m. Eastern Time on Tuesday, August 10, 2021, to discuss its financial results and business highlights.
  • First launched in 2010, Akerna has tracked more than $20 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq.
  • The company's cornerstone technology, MJ Platform, the world's leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators.

Codex DNA to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021

Retrieved on: 
Tuesday, August 3, 2021
Articles, Biotechnology, Economy of New York City, NASDAQ, Synthetic biology

SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), the pioneer in automated benchtop synthetic biology systems, today announced that it will release its second quarter 2021 financial results on Tuesday, August 10, 2021.

Key Points: 
  • SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), the pioneer in automated benchtop synthetic biology systems, today announced that it will release its second quarter 2021 financial results on Tuesday, August 10, 2021.
  • Company management will host a conference call on Tuesday, August 10, 2021, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.
  • The press release and live audio webcast can be accessed via the Investor section of the Companys website at www.codexdna.com.
  • Codex DNA is empowering scientists with the ability to address many of humanitys greatest challenges through synthetic biology.